Clotiapine
Structural formula | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
General | ||||||||||||||||
Surname | Clotiapine | |||||||||||||||
other names |
|
|||||||||||||||
Molecular formula | C 18 H 18 ClN 3 S | |||||||||||||||
Brief description |
white solid |
|||||||||||||||
External identifiers / databases | ||||||||||||||||
|
||||||||||||||||
Drug information | ||||||||||||||||
ATC code | ||||||||||||||||
properties | ||||||||||||||||
Molar mass | 343.87 g mol −1 | |||||||||||||||
Physical state |
firmly |
|||||||||||||||
density |
1.24 g cm −3 |
|||||||||||||||
Melting point |
118-120 ° C |
|||||||||||||||
solubility |
slightly soluble in chloroform , DMSO and methanol |
|||||||||||||||
safety instructions | ||||||||||||||||
|
||||||||||||||||
Toxicological data | ||||||||||||||||
As far as possible and customary, SI units are used. Unless otherwise noted, the data given apply to standard conditions . |
Clotiapine (trade name: Entumin ) is a chemical compound that belongs to the dibenzothiazepines . It is used as a neuroleptic . It has been approved in Switzerland since 1967 for the treatment of schizophrenia and other mental illnesses.
Effects
Clotiapine is a strongly sedating neuroleptic with high side effects. It can cause pancreatitis .
See also
Individual evidence
- ↑ a b c d e Entry on Clotiapine at Toronto Research Chemicals , accessed on July 30, 2017 ( PDF ).
- ^ Carl L. Yaws: Thermophysical Properties of Chemicals and Hydrocarbons . William Andrew, 2014, ISBN 978-0-323-29060-9 , p. 335.
- ↑ Richard J. Lewis: Hazardous Chemicals Desk Reference . John Wiley & Sons, 2008, ISBN 0-470-33445-2 , p. 1472.
- ↑ Pharmawiki: Clotiapine.
- ↑ technical information Entumin (Medius AG), as of April, 2013.
- ^ Margot Schmitz, Rainer Dorow: 1 × 1 of the psychotropic drugs basics, standard therapies and new concepts . Springer-Verlag, 2013, ISBN 978-3-662-05542-7 , p. 157.
- ^ JK Aronson: Meyler's Side Effects of Psychiatric Drugs . Elsevier, 2009, ISBN 978-0-444-53266-4 , p. 261.